A detailed history of Princeton Global Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Princeton Global Asset Management LLC holds 650 shares of LLY stock, worth $486,206. This represents 0.12% of its overall portfolio holdings.

Number of Shares
650
Previous 558 16.49%
Holding current value
$486,206
Previous $505,000 13.86%
% of portfolio
0.12%
Previous 0.12%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$772.14 - $960.02 $71,036 - $88,321
92 Added 16.49%
650 $575,000
Q1 2024

Apr 29, 2024

SELL
$592.2 - $792.28 $1,776 - $2,376
-3 Reduced 0.53%
558 $434,000
Q4 2023

Jan 22, 2024

BUY
$525.19 - $619.13 $2,100 - $2,476
4 Added 0.72%
561 $327,000
Q1 2023

Apr 20, 2023

BUY
$310.63 - $364.82 $15,531 - $18,241
50 Added 9.86%
557 $191,000
Q2 2022

Aug 04, 2022

SELL
$278.73 - $327.27 $9,755 - $11,454
-35 Reduced 6.46%
507 $164,000
Q1 2022

May 06, 2022

SELL
$234.69 - $291.66 $19,479 - $24,207
-83 Reduced 13.28%
542 $155,000
Q3 2021

Nov 08, 2021

BUY
$221.6 - $272.71 $106,589 - $131,173
481 Added 334.03%
625 $144,000
Q3 2021

Nov 03, 2021

SELL
$221.6 - $272.71 $106,589 - $131,173
-481 Reduced 76.96%
144 $144,000
Q1 2021

May 11, 2021

BUY
$164.32 - $212.72 $13,638 - $17,655
83 Added 15.31%
625 $117,000
Q3 2020

Oct 27, 2020

SELL
$146.22 - $169.13 $136,423 - $157,798
-933 Reduced 63.25%
542 $80,000
Q2 2020

Aug 11, 2020

BUY
$136.42 - $164.18 $40,925 - $49,254
300 Added 25.53%
1,475 $242,000
Q1 2020

Apr 28, 2020

BUY
$119.05 - $147.35 $9,166 - $11,345
77 Added 7.01%
1,175 $163,000
Q4 2019

Feb 10, 2020

BUY
$106.92 - $132.43 $67,680 - $83,828
633 Added 136.13%
1,098 $144,000
Q3 2019

Dec 03, 2019

SELL
$106.79 - $116.16 $19,222 - $20,908
-180 Reduced 27.91%
465 $52,000
Q4 2018

Feb 26, 2019

BUY
$105.9 - $118.64 $68,305 - $76,522
645 New
645 $75,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Princeton Global Asset Management LLC Portfolio

Follow Princeton Global Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Global Asset Management LLC with notifications on news.